Chris P. Doe

Systemic Activation of the Transient Receptor Potential Vanilloid Subtype 4 Channel Causes Endothelial Failure and Circulatory Collapse: Part 2

Robert N. Willette, Weike Bao, Sandhya S. Nerurkar et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 295 citations

Life Sciences, Pharmacology, Physiology +17

Novel Rho Kinase Inhibitors with Anti-inflammatory and Vasodilatory Activities

Chris P. Doe, Ross Bentley, David J. Behm et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 156 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Differential Effects of p38 Mitogen-Activated Protein Kinase and Cyclooxygenase 2 Inhibitors in a Model of Cardiovascular Disease

Robert N. Willette, Marianne Eybye, Alan R. Olzinski et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 52 citations

Medicine, Pharmacology, Pharmacotherapy +17

Pharmacological Profile of AZD8871 (LAS191351), a Novel Inhaled Dual M3 Receptor Antagonist/β2-Adrenoceptor Agonist Molecule with Long-Lasting Effects and Favorable Safety Profile

Mònica Aparici, Carla Carcasona, Israel Ramos et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 22 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Pharmacological preclinical characterization of LAS190792, a novel inhaled bifunctional muscarinic receptor antagonist /β 2 -adrenoceptor agonist (MABA) molecule

Mònica Aparici, Carla Carcasona, Israel Ramos et al. · Pulmonary Pharmacology & Therapeutics · 2017 · 20 citations

Medicine, Medicinal Chemistry, Pharmacology +12